Avalo Therapeutics (AVTX) said Thursday it appointed Jennifer Riley to the newly created role of chief strategy officer, effective Wednesday.
Riley most recently founded Northbrook Consulting, Avalo Therapeutics said.
The company's shares were up 9.4% in recent trading.
Price: 8.13, Change: +0.70, Percent Change: +9.42